Multiple gene-deletion vaccinia virus Tiantan strain against mpox
Open Access
- 25 January 2025
- journal article
- research article
- Published by Springer Nature in Virology Journal
- Vol. 22 (1) , 1-10
Abstract
Monkeypox virus (MPXV) is an important zoonotic pathogenic virus, which poses serious threats to public health. MPXV infection can be prevented by immunization against the variola virus. Because of the safety risks and side effects of vaccination with live vaccinia virus (VACV) strain Tian Tan (VTT), we constructed two gene-deleted VTT recombinants (TTVAC7 and TTVC5). The immunogenicity and protective effects of the gene-deleted VTT vaccine were assessed using BALB/C mice challenged with VTT and New Zealand rabbits challenged with MPXV. The results demonstrated strong humoral and cellular immune responses. The VTT-specific and neutralizing antibody titers, specific T cell levels, and degree of dendritic cell maturation of the mice, in addition to the MPXV neutralizing antibody titers and IFN-γ, IL-6, and TNF-α levels of the rabbits were markedly higher in the groups immunized with TTVAC7 and TTVC5 than the control groups (p < 0.05). Moreover, immunization with TTVAC7 and TTVC5 reduced morbidities caused by VACV and MPXV infection. The weight change, lung histological score, and residual virus of the mouse model (p < 0.05). Similarly, the temperature change, pock number, lung histological score, and residual virus of the rabbit model were significantly reduced in the groups immunized with TTVAC7 and TTVC5 (p < 0.05). Collectively, these results demonstrate that TTVAC7 and TTVC5 may be used as potential live attenuated vaccines against MPXV infection.Keywords
Funding Information
- National Key Research and Development Program of China (2023YFD1800404)
- National Natural Science Foundation of China (32402979)
This publication has 41 references indexed in Scilit:
- The 2023 – 2024 multi-source mpox outbreaks of Clade I MPXV in sub-Saharan Africa: Alarm bell for Africa and the WorldInternational Journal of Infectious Diseases, 2024
- Human MHC Class II and Invariant Chain Knock‐in Mice Mimic Rheumatoid Arthritis with Allele Restriction in Immune Response and Arthritis AssociationAdvanced Science, 2024
- Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese populationCell Reports, 2023
- An MPXV mRNA-LNP vaccine candidate elicits protective immune responses against monkeypox virusChinese Chemical Letters, 2023
- Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activityScience China Life Sciences, 2023
- The role of inflammatory signaling pathways involving the CD40L-CD40-TRAF cascade in animal models of diabetes and hypertension as well as coronary artery disease patientsFree Radical Biology and Medicine, 2023
- Monkeypox: A potential global threat?Journal of Medical Virology, 2022
- Seven major genomic deletions of vaccinia virus Tiantan strain are sufficient to decrease pathogenicityAntiviral Research, 2016
- NYVAC: A highly attenuated strain of vaccinia virusVirology, 1992
- Insertional inactivation of the large subunit of ribonucleotide reductase encoded by vaccinia virus is associated with reduced virulence in vivoVirology, 1990